Investing

Shattuck Labs : STTK

STTK

Stock Data

$7.49

$0.31 (4.32%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Shattuck Labs Inc is a biotechnology firm based in Austin, Texas, focusing on creating treatments for cancer and autoimmune diseases. With its flagship product, SL-172154, currently undergoing Phase 1 clinical trials aimed at tackling ovarian, fallopian tube, and peritoneal cancers, the company represents a pioneering force in the medical research field since its inception in 2016.

All Shattuck Labs Articles

2 Articles

Lee Jackson | Jul 24, 2026 at 8:00 AM EDT

Here Are Friday’s Top Wall Street Analyst Research Calls: Albertsons, Blue Owl Capital, Cleveland-Cliffs, Chime Financial, Digital Realty, Dover, PayPal Holdings, SpaceX, and More

Markets took a brutal hit Thursday as oil prices, surging interest rates, and Middle East tensions sent every major index…

Trey Thoelcke | Sep 17, 2025 at 8:45 AM EDT

Elon Musk Leads Insider Buying Wave

The highlight of recent insider buying is an enormous purchase of Tesla shares by CEO Elon Musk. But it wasn't…